Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer

NCT02857218 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Inadequate enrollment

Conditions

Stage IIB Esophageal Cancer AJCC v7
Stage III Esophageal Cancer AJCC v7
Stage IIIA Esophageal Cancer AJCC v7
Stage IIIB Esophageal Cancer AJCC v7
Stage IIIC Esophageal Cancer AJCC v7

Interventions

DRUG: Ferumoxytol
PROCEDURE: Magnetic Resonance Imaging

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]